The company, established in 1973, has a motto ‘to develop better drugs for precious lives’, and aims to advance to the global market as a representative of the Korean pharmaceutical industry by focusing on research and development.

It is expected to become the first Korean company to develop a new global drug as clinical trials are conducted in the USA and Europe to develop diabetes and anti-cancer drugs.